• BRIGHT BRAINS ATTRACT BRIGHT BRAINS, Matthew principle BBABB

Chance favours the prepared mind

Selected Presentations

Molecular and functional neuroimaging in clinical neurosciences.

Lanzenberger, 16.06.2012

Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, China.

Functional Neuroimaging - PET & fMRI

PET in imaging genetics

Lanzenberger, 17.01.2012

8th Annual International Imaging Genetics Conference
The Beckman Center of the National Academy of Sciences in Irvine, 16-17 Jan. 2012, California, USA

Effects of SSRI administration on 5-HT1A BP, 5-HTT occupancy, and neural activation ([11C]WAY PET, [11C]DASB PET, phfMRI, multimodal)

Lanzenberger, 02.06.2009

METPETS Consortium - Inaugural Meeting Measuring Endogenous Neurotransmitters by PET and SPECT
Carlsberg Akademi, June 2-3 2009, Valby, Copenhagen, Denmark

Hormones and the Brain

23. April 2008: PD Dr. Lanzenberger's talk at the "Gesellschaft der Ärzte in Wien" (Billrothhaus)

Watch Video in new Window

Serotonin in anxiety and affective disorders

Lanzenberger, 09.04.2009

Rupert Lanzenberger in Edinburgh

European Psychiatric Association (EPA) Meeting "Brain, Behaviour and Genes", April 9th - 10th 2009, Old College, Edinburgh, GB

Multimodal neuroimaging by combining PET and functional MRI

Lanzenberger, 03.03.2009

International Research Training Group (IRTG) Meeting
Klinik für Psychiatrie und Psychotherapie der RWTH , Aachen, Germany

Talks 2011

  • Treatment effects of SSRIs on serotonergic neurotransmission in depression and anxiety disorders
    Lanzenberger, x.09.2011
    Symposium: Imaging the Serotonergic Transmitter System in Humans: A Multimodality Approach
    24th ECNP Congress, 3-7 September 2011, Paris, France
  • Imaging the serotonergic system
    Lanzenberger, 1x.03.2011
    Core Symposium: Neuroimaging as a diagnostic tool
    19th European Congress of Psychiatry (EPA), 12-15 March 2011, Vienna, Austria
  • The molecular and functional network in SSRI treatment
    Lanzenberger, 1x.03.2011
    Symposium: Molecular Systems Biology in Psychiatric Disorders
    19th European Congress of Psychiatry (EPA), 12-15 March 2011, Vienna, Austria


Talks 2010


Talks 2009

  • Multimodal neuroimaging by combining PET and functional MRI
    Lanzenberger, 26.11.2009
    Symposium Advanced MR-Imaging
    DGPPN Kongress (Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde), 25.-28.11.2009, Berlin, Germany
  • Molecular Imaging in der Psychiatrie
    Lanzenberger, 03.10.2009
    Symposium anlässlich der Installation eines PET/CT-Scanners
    LKH Feldkirch, Austria
  • Imaging genetics: Putative Role in Clinical Psychiatry
    Lanzenberger (PET), Pezawas (fMRI, sMRI), 13.09.2009
    Brainstorming Session
    22nd ECNP Congress, 12-16 September 2009, Istanbul, Turkey
  • Serotonin-1A receptor binding potential in dorsal raphe nuclei predicts orbitofrontal reactivity in healthy subjects
    Hahn, 13.09.2009
    Young Scientists Award Symposium 1
    22nd ECNP Congress, 12-16 September 2009, Istanbul, Turkey
  • Effects of SSRIs on brain serotonin function revealed by PET and phfMRI
    Lanzenberger, 29.06.2009
    Symposium: Positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) of human brain monoamine neurotransmission.
    9th World Congress of Biological Psychiatry (WFSBP), 28 June - 2 July 2009, Paris, France
  • Amygdala hyperactivity in social anxiety disorder induced by facial attractiveness
    Hahn, 28.06.2009
    Young Scientist Award Session
    9th World Congress of Biological Psychiatry (WFSBP), 28 June - 2 July 2009, Paris, France
  • Neuroimaging findings in psychiatric disorders (Opening Lecture)
    Lanzenberger, 10.06.2009
    XIV Konference Biologické Psychiatrie, 10 - 13 june 2009, Luhacovice, Czech Republic
  • Effects of SSRI administration on 5-HT1A BP, 5-HTT occupancy, and neural activation ([11C]WAY PET, [11C]DASB PET, phfMRI, multimodal)
    Lanzenberger, 02.06.2009
    METPETS Consortium - Inaugural Meeting Measuring Endogenous Neurotransmitters by PET and SPECT
    Carlsberg Akademi, June 2-3 2009, Valby, Copenhagen, Denmark
  • 5HT in anxiety and affective disorders
    Lanzenberger, 09.04.2009
    European Psychiatric Association (EPA) Meeting „Brain, Behaviour and Genes“
    April 9th - 10th 2009, Old College, Edinburgh, GB
  • Serotonin in anxiety and affective disorders
    Lanzenberger, 08.04.2009
    Invited Lecture at the Wolfson Molecular Imaging Centre, University of Manchester, GB
  • Wird die präfrontale Aktivität durch die Serotonin-1A Rezeptoren im dorsalen Raphenukleus moduliert?
    Lanzenberger, 16.03.2009
    WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 15.-21. März 2009, Oberlech, Austria
  • Aggression und frontale Serotonin-1A Rezeptorbindung
    Savli, 16.03.2009
    WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 15.-21. März 2009, Oberlech, Austria
  • Serotonin-1A receptor binding potential in dorsal raphe nuclei predicts orbitofrontal reactivity in healthy subjects
    Hahn, 06.03.2009
    ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe, 5 - 8 March 2009, Nice, France
  • Multimodal neuroimaging by combining PET and functional MRI
    Lanzenberger, 03.03.2009
    International Research Training Group (IRTG) Meeting
    Klinik für Psychiatrie und Psychotherapie der RWTH , Aachen, Germany
  • Neuroimaging der Depression: Relevanz für die Praxis?
    Lanzenberger, 28.02.2009
    Fortbildungsreihe - Psychiatrie in Wissenschaft und Praxis
    MUW, Vienna, Austria


Talks 2008

  • Changes in binding of serotonin-1A receptor and serotonin transporter by SSRI treatment revealed with PET
    Lanzenberger, 10.10.2008
    7. Drei-Länder-Symposiums für Biologische Psychiatrie
    9. - 11. Oktober 2008, Göttingen, Germany
  • Multimodal neuroimaging in anxiety disorders by combining PET and functional MRI
    Lanzenberger, 10.10.2008
    7. Drei-Länder-Symposiums für Biologische Psychiatrie
    9. - 11. Oktober 2008, Göttingen, Germany
  • ZNS Tracer für die PET
    Lanzenberger, 06.10.2008
    Fortbildungsveranstaltung
    Univ.Klinik f. Radiodiagnostik; AKH Wien, Austria
  • Neuroimaging in addiction: resolved issues and new challenges
    Lanzenberger, 30.08.2008
    Target Expert Meeting (TEM)
    21st ECNP Congress, 30.8. - 3.9.2008, Barcelona, Spain
  • Does progesterone regulate the serotonergic neurotransmission in men?
    Lanzenberger, 14.07.2008
    50th Anniversary of CINP, Symposiums "The role of 5-HT1A receptors in treatment and understanding of depression and anxiety disorders"
    Collegium Internationale of Neuro-Psychopharmacologicum (CINP)
    26th CINP Congress, July 13 - 17, 2008, Munich, Germany
  • Wie Steroidhormone die Neurotransmission des Gehirn beeinflussen
    Lanzenberger, 23.04.2008 Sitzung in der Gesellschaft der Ärzte, Wien, Austria
  • Sexualhormone und Entwicklung im Bereich des Gehirns
    Lanzenberger, 02.04.2008
    Ringvorlesung der Stabsstelle GENDER Mainstreaming, SS 2008 (902082)
    MUW, Vienna, Austria
  • Multimodale und Multitracer Studien mit PET und fMRT
    Lanzenberger, 03.03.2008
    WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 3.- 7. März 2008, Oberlech, Austria
  • PET Auswertung bei psychiatrischen Studie
    Savli, 03.03.2008
    WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 3.- 7. März 2008, Oberlech, Austria
  • Multimodal imaging using PET and functinonal MRI reveals inverse relation between serotonin-1A receptor binding and neural activation
    Lanzenberger, 12.01.2008
    Radioactive Isotopes in Clinical Medicine and Research
    28th International Symposium, January 9-12, 2008, Bad Hofgastein, Austria


Talks 2007

  • Biologie der Angststörungen
    Lanzenberger, 29.11.2007
    Wissenschaftliches Seminar
    Universitätsklinik für Psychiatrie, MUW, Austria
  • Anwendungen von PET in der Psychiatrie, Teil 2
    Lanzenberger, 21.11.2007
    Department of Nuclear Medicine, MUW, Vienna, Austria
  • Anwendungen von PET in der Psychiatrie, Teil 1
    Lanzenberger, 14.11.2007
    Department of Nuclear Medicine, MUW, Vienna, Austria
  • Kann man die Angst im Gehirn darstellen?
    Lanzenberger, 09.11.2007
    9. Tagung der Österreichischen Gesellschaft für Neuropsychopharmakologie und Biologische Psychiatrie (ÖGBP), Wien, Austria
  • Advances in NeuroImaging - Methodische Entwicklungen im Bereich Neuroimaging
    Lanzenberger, 08.11.2007
    Satellitenworkshop, Sponsor: Lundbeck
    Collegium Internationale of Neuro-Psychopharmacologicum (CINP)
    9. Tagung der Österreichischen Gesellschaft für Neuropsychopharmakologie und Biologische Psychiatrie (ÖGBP), Wien, Austria
  • How sex hormones influence the brain in men and women
    Lanzenberger, 02.06.2007
    2nd International Congress of Gender Medicine, June 2 - 3, 2007, Vienna, Austria
  • Serotonin 1A receptor level affects neural activation revealed by combining PET and functional MRI
    Lanzenberger, 18.04.2007
    2nd International Congress of Biological Psychiatry, April 17-21, 2007, Santiago de Chile, Chile
  • Wie viel Gehirn braucht der Affekt? Bildgebende Verfahren u. affektive Symptome bei Schizophrenie
    Lanzenberger, Kasper 13.04.2007
    Grazer Psychosentage, 13.-14.4.2007, Graz, Österreich
  • Kombinierte fMRT/PET des monoaminergen Systems bei psychiatrischen Störungen
    Lanzenberger, 23.03.2007
    51. Jahrestagung der Deutsche Gesellschaft für Klinische Neurophysiologie und Funktionelle Bildgebung (DGKN), München, 21.-25.3.2007
  • Multimodal NeuroImaging of the serotonergic system using PET and fMRI
    Lanzenberger, 13.03.2007
    WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 13. März 2007, Oberlech, Austria
  • Ist bei Angsterkrankungen die serotonerge Inhibition reduziert? - Eine PET Studie mit [11C]WAY-100635
    Lanzenberger, 26.01.2007
    Jahrestagung der Österreichischen Gesellschaft für Nuklearmedizin, 25. - 27. Januar 2007, Linz, Austria


Videos

Hormones and the Brain

Rotating Brain

See a serotonin-1A receptor binding potential map overlaid onto a 3D structural MRI

PET in imaging devices


Rupert Lanzenberger and Pia Baldinger at the Beckman Center